Literature DB >> 27496110

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Daniel G Coit1, John A Thompson1, Alain Algazi1, Robert Andtbacka1, Christopher K Bichakjian1, William E Carson1, Gregory A Daniels1, Dominick DiMaio1, Ryan C Fields1, Martin D Fleming1, Brian Gastman1, Rene Gonzalez1, Valerie Guild1, Douglas Johnson1, Richard W Joseph1, Julie R Lange1, Mary C Martini1, Miguel A Materin1, Anthony J Olszanski1, Patrick Ott1, Aparna Priyanath Gupta1, Merrick I Ross1, April K Salama1, Joseph Skitzki1, Susan M Swetter1, Kenneth K Tanabe1, Javier F Torres-Roca1, Vijay Trisal1, Marshall M Urist1, Nicole McMillian1, Anita Engh1.   

Abstract

The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN Guidelines Insights summarize the data and rationale supporting extensive changes to the recommendations for systemic therapy in patients with metastatic or unresectable melanoma.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27496110     DOI： 10.6004/jnccn.2016.0101

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  28 in total

Review 1.  Diagnosis and Management of Acral Lentiginous Melanoma.

Authors:  Yoshiyuki Nakamura; Yasuhiro Fujisawa
Journal:  Curr Treat Options Oncol       Date:  2018-06-27

2.  Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Authors:  Mark B Faries; John F Thompson; Alistair J Cochran; Robert H Andtbacka; Nicola Mozzillo; Jonathan S Zager; Tiina Jahkola; Tawnya L Bowles; Alessandro Testori; Peter D Beitsch; Harald J Hoekstra; Marc Moncrieff; Christian Ingvar; Michel W J M Wouters; Michael S Sabel; Edward A Levine; Doreen Agnese; Michael Henderson; Reinhard Dummer; Carlo R Rossi; Rogerio I Neves; Steven D Trocha; Frances Wright; David R Byrd; Maurice Matter; Eddy Hsueh; Alastair MacKenzie-Ross; Douglas B Johnson; Patrick Terheyden; Adam C Berger; Tara L Huston; Jeffrey D Wayne; B Mark Smithers; Heather B Neuman; Schlomo Schneebaum; Jeffrey E Gershenwald; Charlotte E Ariyan; Darius C Desai; Lisa Jacobs; Kelly M McMasters; Anja Gesierich; Peter Hersey; Steven D Bines; John M Kane; Richard J Barth; Gregory McKinnon; Jeffrey M Farma; Erwin Schultz; Sergi Vidal-Sicart; Richard A Hoefer; James M Lewis; Randall Scheri; Mark C Kelley; Omgo E Nieweg; R Dirk Noyes; Dave S B Hoon; He-Jing Wang; David A Elashoff; Robert M Elashoff
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

3.  JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapy.

Authors:  Sounak Gupta; Chad M Vanderbilt; Paolo Cotzia; Javier A Arias Stella; Jason C Chang; Yingbei Chen; Laura H Tang; Deborah F DeLair; Jinjuan Yao; Marc Ladanyi; Dara S Ross
Journal:  Hum Pathol       Date:  2018-09-18       Impact factor: 3.466

4.  Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.

Authors:  Fang Zheng; Jianzhong Dang; Hongyu Zhang; Fangzhou Xu; Diandian Ba; Bingyu Zhang; Fanjun Cheng; Alfred E Chang; Max S Wicha; Qiao Li
Journal:  J Immunother       Date:  2018-10       Impact factor: 4.456

5.  Clinical significance of BRAFV600E mutation in circulating tumor DNA in Chinese patients with melanoma.

Authors:  Huan Tang; Yan Kong; Lu Si; Chuanliang Cui; Xinan Sheng; Zhihong Chi; Jie Dai; Sifan Yu; Meng Ma; Xiaowen Wu; Jiayi Yu; Tianxiao Xu; Huan Yu; Junya Yan; Jun Guo
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

Review 6.  Lymphedema secondary to melanoma treatments: diagnosis, evaluation, and treatments.

Authors:  Azuelos Arié; Takumi Yamamoto
Journal:  Glob Health Med       Date:  2020-08-31

7.  Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.

Authors:  Mohammed Kashani-Sabet; Mehdi Nosrati; James R Miller; Richard W Sagebiel; Stanley P L Leong; Andrew Lesniak; Schuyler Tong; Sandra J Lee; John M Kirkwood
Journal:  Clin Cancer Res       Date:  2017-08-08       Impact factor: 12.531

Review 8.  Dermoscopic Features as Predictors of BRAF Mutational Status and Sentinel Lymph Node Positivity in Primary Cutaneous Melanoma.

Authors:  Nika Filipović; Mirna Šitum; Marija Buljan
Journal:  Dermatol Pract Concept       Date:  2021-04-12

9.  Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program.

Authors:  Evangelia Katsoulakis; Jill E Duffy; Bradley Hintze; Neil L Spector; Michael J Kelley
Journal:  JCO Precis Oncol       Date:  2020-03-24

Review 10.  The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.

Authors:  Charles J Puza; Paul J Mosca
Journal:  Lasers Med Sci       Date:  2017-09-11       Impact factor: 3.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.